leadf
logo-loader
LSE:CIR

Circassia Group PLC

Receive alerts
Market:
LSE
Market Cap:
£97.05 m
Price
24.43 GBX
Change
3.28%
52 weeks high
33.40
52 weeks low
0.26

In brief

Circassia is a specialty pharmaceutical company focused on respiratory disease. Our commercial organization promotes our innovative asthma management products directly to specialist physicians in a number of key markets, and we market the chronic obstructive pulmonary disease (COPD) products Tudorza® and Duaklir® in the United States. Recently, we significantly expanded our commercial platform in China, launching our own direct sales team. We are working to expand our portfolio further through in-licensing, partnering or acquisition, and in 2019 we acquired the commercial rights to the ventilator-compatible nitric oxide product LungFit PH* in the US and China.